Literature DB >> 10955775

C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.

L Wang1, S H Lin, W G Wu, B L Kemp, G L Walsh, W K Hong, L Mao.   

Abstract

Previous studies have shown that the expression of the cell-cell adhesion molecule (C-CAM1), located at chromosome 19, is down-regulated in several types of human cancers, including prostate and breast cancers. Two major isoforms of C-CAM1, the long or L-form C-CAM1 and the short or S-form C-CAM1, are derived from the C-CAM1 gene through alternative splicing. Tumor cells transfected with L-form C-CAM1, which contains a cytoplasmic domain, display significantly lower growth rates and less tumorigenicity in both in vitro and in vivo models compared with untransfected tumor cells, suggesting that L-form C-CAM1 may be a tumor suppressor. The transfection of the cytoplasmic domain of L-form C-CAM1 could also cause suppression of tumor growth, further supporting the role of L-form C-CAM1 in tumorigenesis. In contrast to reports of most of the tumor types tested, Ohwada et al. (Am. J. Respir. Cell Mol. Biol., 11: 214-220, 1994) reported that C-CAM1 was not down-regulated or even up-regulated in lung cancer. Because the cytoplasmic domain of L-form C-CAM1 is critical for the tumor suppressor function of C-CAM1, we hypothesized that switching of the isoform rather than down- regulation of C-CAM1 gene expression occurs during lung tumorigenesis. To test this hypothesis, we analyzed pairs of tumor tissue and corresponding normal-appearing lung tissue from 51 patients with non-small cell lung cancer (NSCLC) and 43 cell lines to determine expression profiles of L-form C-CAM1 and S-form C-CAM1 using reverse transcription-PCR. We found that L-form C-CAM1 was the predominant form (75%; 38 of 51) in normal-appearing lung tissue, whereas most (84%; 43 of 51) of the primary NSCLC tissue samples expressed predominantly S-form C-CAM1 (P < 0.0001). Similarly, 19 (79%) of the 24 NSCLC cell lines and 17 (85%) of the 20 small cell lung cancer cell lines expressed predominantly S-form C-CAM1. The frequent alteration of the C-CAM1 expression pattern suggests that C-CAM1 has an important role in lung tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10955775

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  15 in total

1.  Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.

Authors:  Rongze Lu; Maciej Kujawski; Hao Pan; John E Shively
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

2.  Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer.

Authors:  Chen Zhang; Haoran Li; Yujie Huang; Yuchen Tang; Jie Wang; Yinxiang Cheng; Yijun Wei; Dongming Zhu; Zhifei Cao; Jian Zhou
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer.

Authors:  Ruben Pio; David Blanco; Maria Jose Pajares; Elena Aibar; Olga Durany; Teresa Ezponda; Jackeline Agorreta; Javier Gomez-Roman; Miguel Angel Anton; Angel Rubio; Maria D Lozano; Jose M López-Picazo; Francesc Subirada; Tamara Maes; Luis M Montuenga
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

4.  CEACAM1 is overexpressed in oral tumors and related to tumorigenesis.

Authors:  Fu-Fang Wang; Bing-Xin Guan; Jing-Yan Yang; Hai-Tao Wang; Cheng-Jun Zhou
Journal:  Med Mol Morphol       Date:  2016-07-27       Impact factor: 2.309

5.  SpliceNet: recovering splicing isoform-specific differential gene networks from RNA-Seq data of normal and diseased samples.

Authors:  Hari Krishna Yalamanchili; Zhaoyuan Li; Panwen Wang; Maria P Wong; Jianfeng Yao; Junwen Wang
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

6.  Clinical and experimental studies regarding the expression and diagnostic value of carcinoembryonic antigen-related cell adhesion molecule 1 in non-small-cell lung cancer.

Authors:  Mu-qing Zhou; Yan Du; Yi-wen Liu; Ying-zhi Wang; Yi-qing He; Cui-xia Yang; Wen-juan Wang; Feng Gao
Journal:  BMC Cancer       Date:  2013-07-25       Impact factor: 4.430

7.  Deregulation of the CEACAM expression pattern causes undifferentiated cell growth in human lung adenocarcinoma cells.

Authors:  Bernhard B Singer; Inka Scheffrahn; Robert Kammerer; Norbert Suttorp; Suleyman Ergun; Hortense Slevogt
Journal:  PLoS One       Date:  2010-01-18       Impact factor: 3.240

Review 8.  Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.

Authors:  Anna Śledzińska; Laurie Menger; Katharina Bergerhoff; Karl S Peggs; Sergio A Quezada
Journal:  Mol Oncol       Date:  2015-10-26       Impact factor: 6.603

9.  Altered splicing of CEACAM1 in breast cancer: identification of regulatory sequences that control splicing of CEACAM1 into long or short cytoplasmic domain isoforms.

Authors:  Shikha Gaur; John E Shively; Yun Yen; Rajesh K Gaur
Journal:  Mol Cancer       Date:  2008-05-28       Impact factor: 27.401

10.  Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer.

Authors:  Liqiang Xi; Andrew Feber; Vanita Gupta; Maoxin Wu; Andrew D Bergemann; Rodney J Landreneau; Virginia R Litle; Arjun Pennathur; James D Luketich; Tony E Godfrey
Journal:  Nucleic Acids Res       Date:  2008-10-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.